Recent large spenders include Abbvie’s anti-inflammatory drug Skyrizi, which has spent nearly $400 million in linear TV ads this year in the U.S., and Novo Nordisk’s weight-loss drug Wegovy ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be complicated.

We agree that direct-to-consumer prescription-drug advertisements need to be reformed.

But there’s another downside that’s unlisted, one that’s not associated with the medication but the TV commercial itself: critics say such direct-to-consumer drug ads — which are ...

The commercial appears to be taking advantage of a perceived loophole in federal law regarding promotions of compounded drugs by telehealth companies, according to a press release from Sen. Durbin.

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

WEDNESDAY, Feb. 12, 2025 (HealthDay News) -- Commercials run by the telehealth company Hims & Hers have been placed under the ...

ALMANAC: Feb 9 "Sunday Morning" looks back at historical events on this date.

Currently, it’s legal to market prescription drugs on television ... The prices won’t actually be shown in the TV commercials, but the advertisement will include a website where the list ...

Not only did AbbVie’s Skyrizi claim first place in the full-year ranking with nearly $377 million spent on 20 separate ads for the drug, according to iSpot.TV’s analysis, but, with two other ...